StatCounter

venerdì 31 maggio 2019

ESMO European Ssociety for Medical Oncology

FDA Approves Alpelisib for Metastatic Breast Cancer 

It also approved the companion diagnostic test to select patients who have PIK3CA mutations in tumour tissue specimens and/or in ctDNA